Business

LTM Secures Strategic Engagement with a Global Banking and Financial Services Firm

Oct 27, 2026

BusinessWire India
Mumbai (Maharashtra) [India], October 27: LTM, the Business Creativity partner to the world's largest enterprises, has secured a strategic engagement with a large global banking and financial services firm, further strengthening its position as a trusted technology and transformation partner to leading financial institutions. This two-year engagement is already underway with an option to extend for an additional year and has a potential value of up to USD 100 million.
The engagement reflects the continued expansion of LTM’s relationship with the client and its growing role in advancing strategic technology programmes and supporting supplier consolidation initiatives across the organization. Under the agreement, LTM will serve as a preferred partner driving the consolidation and delivery of strategic technology requirements across key wealth, personal banking, and global functions.
The engagement will leverage LTM’s deep banking-domain expertise, engineering excellence, and global delivery capabilities to support the client’s technology transformation priorities at scale.
This engagement reinforces LTM’s commitment to building long-term strategic partnerships with global financial institutions and delivering measurable business outcomes through technology, engineering, and transformation services. By combining industry expertise with AI-led engineering capabilities, LTM continues to help clients enhance productivity, accelerate modernization, and scale AI-infused delivery across the enterprise.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by BusinessWire India. ANI will not be responsible in any way for the content of the same.)

More news

Micro Labs Marks 53 Years of Growth, Building a Global Presence Through Quality and Innovation

Bengaluru (Karnataka) [India], October 27: Micro Labs Limited, the Bengaluru-headquartered pharmaceutical company, marks five decades of operations with a presence in more than 50 countries, 17 manufacturing units, a workforce of 15,000 employees, and a portfolio of over 400 products. Privately held and family-run, the company has grown into one of India’s top 20 pharmaceutical players, building its business around quality, product development and long-term relationships with healthcare professionals.

Oct 27, 2026